A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns.
The EMA said the review was due to reports of conditions affecting blood vessels in the brain in some patients who took pseudoephedrine-containing medicines.
Pseudoephedrine is a drug that is used alone or in combination with other medicines to treat a blocked nose due to cold, flu or allergy.
Makers of pseudoephedrine-containing drugs include Reckitt Benckiser, McNeil Products Ltd and Organon & Co.
(Reporting by Sriparna Roy in Bengaluru; editing by Shounak Dasgupta)
Topics Europe
Was this article valuable?
Here are more articles you may enjoy.
Delta Air Lines Must Face Lawsuit Over ‘Window Seats’ With No Windows 
Manufacturers Hammer IBHS Over 15-Year Roof Age Limit for Fortified Designation 
New Florida Property-Tax Cut May Bring an Unwanted Side Effect 
Georgia, Florida Insurers Facing New Scrutiny, Regulations After Election 
